From the MHRA
“This trial will only be allowed to go ahead if the expert scientific and clinical evidence and advice conclude it is both safe and necessary.”
www.gov.uk/government/n...
gov.uk
PATHWAYS clinical trial paused following new MHRA advice
The MHRA have raised new concerns around the PATHWAYS trial looking into the prescription of puberty blockers among young people with gender incongruence.